| Two treatment approaches for human regular U-500 insulin in patients with type 2 diabetes not achieving adequate glycemic control on high-dose U-100 insulin therapy with or … RC Hood, RF Arakaki, C Wysham, YG Li, JA Settles, JA Jackson Endocrine Practice 21 (7), 782-794, 2015 | 63 | 2015 |
| Multi-Center DevelopmentandTestingof aSimulation-Based Cardiovascular Assessment CurriculumforAdvanced Practice Nurses PR Jeffries, M Beach, SI Decker, L Dlugasch, J Groom, J Settles, ... Nursing education perspectives 32 (5), 316-322, 2011 | 57 | 2011 |
| Glucagon prescription patterns in patients with either type 1 or 2 diabetes with newly prescribed insulin BD Mitchell, X He, IM Sturdy, AP Cagle, JA Settles Endocrine Practice 22 (2), 123-135, 2016 | 44 | 2016 |
| Advanced cardiac life support instruction: do we know tomorrow what we know today? J Settles, PR Jeffries, TM Smith, JS Meyers The Journal of Continuing Education in Nursing 42 (6), 271-279, 2011 | 34 | 2011 |
| Nasal glucagon delivery is more successful than injectable delivery: a simulated severe hypoglycemia rescue JA Settles, GF Gerety, E Spaepen, JG Suico, CJ Child Endocrine Practice 26 (4), 407-415, 2020 | 30 | 2020 |
| Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a … S Kabul, RC Hood, R Duan, AM DeLozier, J Settles Health and quality of life outcomes 14, 1-9, 2016 | 25 | 2016 |
| A database for nurse practitioner clinical education D Cullen, D Stiffler, J Settles, DJ Pesut CIN: Computers, Informatics, Nursing 28 (1), 20-29, 2010 | 14 | 2010 |
| Nasal glucagon is easier to use and more preferred and needs less effort to administer than injectable glucagon: user perceptions of glucagon administration during severe … J Settles, D Hinnen, E Spaepen, S Bajpai, A Turakhiya, S Ghodke, ... Endocrine Practice 28 (5), 486-493, 2022 | 4 | 2022 |
| 13-LB: nasal vs. injected glucagon: user experience results of a simulated severe hypoglycemia study J Settles, CJ Child, SK Bajpai, E Spaepen, JG Suico Diabetes 68 (Supplement_1), 2019 | 3 | 2019 |
| Introducing the new NONPF skills manual S Melander, J Settles The Nurse Practitioner 36 (11), 14, 2011 | 3 | 2011 |
| Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin‐treated type 2 diabetes: Results from a real‐world nested case‐control … J Settles, H Kan, CJ Child, M Gorritz, JK Multani, CB McGuiness, ... Diabetes, Obesity and Metabolism 24 (7), 1235-1244, 2022 | 2 | 2022 |
| Teaching cardiopulmonary assessment skills among advanced practice nurses S Decker, J Pam, S Julie, G Jeffrey, D Lucie Clinical Simulation in Nursing 6 (3), e112, 2010 | 2 | 2010 |
| Making the Web work for acute care NP education R Kleinpell, M Hravnak, J Settles, S Melander The Nurse Practitioner 34 (4), 8-10, 2009 | 2 | 2009 |
| EXPERIENCES OF CAREGIVERS OF CHILDREN AND YOUNG ADULTS WITH TYPE 1 DIABETES RELATED TO SEVERE HYPOGLYCEMIA AND BEING PREPARED WITH NASAL GLUCAGON-A QUALITATIVE STUDY B Mitchell, A Hughes, JL Poon, E Hankosky, K Chapman, M Vanderwel, ... DIABETES TECHNOLOGY & THERAPEUTICS 24, A201-A201, 2022 | 1 | 2022 |
| Potential Risk Factors for Severe Hypoglycemia in Insulin-treated Adults with Type 2 Diabetes (T2D) J Settles, CJ Child, M Gorritz, JK Multani, CB McGuiness, RL Wade, ... Diabetologie und Stoffwechsel 17 (S 01), P 079, 2022 | | 2022 |
| Risk factors for severe hypoglycaemia in adults with insulin-treated type 2 diabetes BM Frier, CJ Child, M Gorritz, JK Multani, CB McGuiness, RL Wade, ... DIABETOLOGIA 64 (SUPPL 1), 156-156, 2021 | | 2021 |
| 1039-P: Potential Risk Factors for Severe Hypoglycemia in Insulin-Treated Adults with Type 2 Diabetes (T2DM) J SETTLES, CJ CHILD, M GORRITZ, JK MULTANI, C MCGUINESS, ... Diabetes 70 (Supplement_1), 2021 | | 2021 |
| Nasal versus injected glucagon: User experience results of a simulated severe hypoglycemia study J Settles, G Gerety, E Spaepen, B Sanjay, JG Suico, CJ Child, E Moennig Diabetologie und Stoffwechsel 16 (S 01), 2021 | | 2021 |
| NASAL VERSUS INJECTED GLUCAGON ADMINISTRATION: EVALUATING OVERALL WORKLOAD IN A SIMULATED SEVERE HYPOGLYCEMIA RESCUE J Settles, E Spaepen, A Turakhiya, C Child DIABETES TECHNOLOGY & THERAPEUTICS 22, A54-A54, 2020 | | 2020 |
| NASAL VERSUS INJECTED GLUCAGON: USER EXPERIENCE RESULTS OF A SIMULATED SEVERE HYPOGLYCEMIA STUDY C Child, G Gerety, S Bajpai, E Spaepen, J Suico, J Settles DIABETES TECHNOLOGY & THERAPEUTICS 22, A54-A54, 2020 | | 2020 |
